These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

735 related items for PubMed ID: 11920401

  • 1. Inadequately low serum levels of steroid hormones in relation to interleukin-6 and tumor necrosis factor in untreated patients with early rheumatoid arthritis and reactive arthritis.
    Straub RH, Paimela L, Peltomaa R, Schölmerich J, Leirisalo-Repo M.
    Arthritis Rheum; 2002 Mar; 46(3):654-62. PubMed ID: 11920401
    [Abstract] [Full Text] [Related]

  • 2. Anti-interleukin-6 receptor antibody therapy favors adrenal androgen secretion in patients with rheumatoid arthritis: a randomized, double-blind, placebo-controlled study.
    Straub RH, Härle P, Yamana S, Matsuda T, Takasugi K, Kishimoto T, Nishimoto N.
    Arthritis Rheum; 2006 Jun; 54(6):1778-85. PubMed ID: 16729287
    [Abstract] [Full Text] [Related]

  • 3. Serum levels of pregnenolone and 17-hydroxypregnenolone in patients with rheumatoid arthritis and systemic lupus erythematosus: relation to other adrenal hormones.
    Vogl D, Falk W, Dorner M, Schölmerich J, Straub RH.
    J Rheumatol; 2003 Feb; 30(2):269-75. PubMed ID: 12563679
    [Abstract] [Full Text] [Related]

  • 4. Long-term anti-tumor necrosis factor antibody therapy in rheumatoid arthritis patients sensitizes the pituitary gland and favors adrenal androgen secretion.
    Straub RH, Pongratz G, Schölmerich J, Kees F, Schaible TF, Antoni C, Kalden JR, Lorenz HM.
    Arthritis Rheum; 2003 Jun; 48(6):1504-12. PubMed ID: 12794817
    [Abstract] [Full Text] [Related]

  • 5. Soluble receptors for tumor necrosis factor and interleukin-2 in serum and synovial fluid of patients with rheumatoid arthritis, reactive arthritis and osteoarthritis.
    Steiner G, Studnicka-Benke A, Witzmann G, Höfler E, Smolen J.
    J Rheumatol; 1995 Mar; 22(3):406-12. PubMed ID: 7783054
    [Abstract] [Full Text] [Related]

  • 6. Increased DHEAS levels in patients with rheumatoid arthritis after treatment with tumor necrosis factor antagonists: evidence for improved adrenal function.
    Ernestam S, Hafström I, Werner S, Carlström K, Tengstrand B.
    J Rheumatol; 2007 Jul; 34(7):1451-8. PubMed ID: 17477470
    [Abstract] [Full Text] [Related]

  • 7. Renal clearance and daily excretion of cortisol and adrenal androgens in patients with rheumatoid arthritis and systemic lupus erythematosus.
    Straub RH, Weidler C, Demmel B, Herrmann M, Kees F, Schmidt M, Schölmerich J, Schedel J.
    Ann Rheum Dis; 2004 Aug; 63(8):961-8. PubMed ID: 15249323
    [Abstract] [Full Text] [Related]

  • 8. Replacement therapy with DHEA plus corticosteroids in patients with chronic inflammatory diseases--substitutes of adrenal and sex hormones.
    Straub RH, Schölmerich J, Zietz B.
    Z Rheumatol; 2000 Aug; 59 Suppl 2():II/108-18. PubMed ID: 11155790
    [Abstract] [Full Text] [Related]

  • 9. Altered function of the hypothalamic stress axes in patients with moderately active systemic lupus erythematosus. II. Dissociation between androstenedione, cortisol, or dehydroepiandrosterone and interleukin 6 or tumor necrosis factor.
    Zietz B, Reber T, Oertel M, Glück T, Schölmerich J, Straub RH.
    J Rheumatol; 2000 Apr; 27(4):911-8. PubMed ID: 10782815
    [Abstract] [Full Text] [Related]

  • 10. Adrenal gland hypofunction in active polymyalgia rheumatica. effect of glucocorticoid treatment on adrenal hormones and interleukin 6.
    Cutolo M, Straub RH, Foppiani L, Prete C, Pulsatelli L, Sulli A, Boiardi L, Macchioni P, Giusti M, Pizzorni C, Seriolo B, Salvarani C.
    J Rheumatol; 2002 Apr; 29(4):748-56. PubMed ID: 11950017
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Hypothalamic-pituitary-adrenal axis impairment in the pathogenesis of rheumatoid arthritis and polymyalgia rheumatica.
    Cutolo M, Foppiani L, Minuto F.
    J Endocrinol Invest; 2002 Apr; 25(10 Suppl):19-23. PubMed ID: 12508908
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Association of humoral markers of inflammation and dehydroepiandrosterone sulfate or cortisol serum levels in patients with chronic inflammatory bowel disease.
    Straub RH, Vogl D, Gross V, Lang B, Schölmerich J, Andus T.
    Am J Gastroenterol; 1998 Nov; 93(11):2197-202. PubMed ID: 9820396
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Sex hormone concentrations in patients with rheumatoid arthritis are not normalized during 12 weeks of anti-tumor necrosis factor therapy.
    Straub RH, Härle P, Atzeni F, Weidler C, Cutolo M, Sarzi-Puttini P.
    J Rheumatol; 2005 Jul; 32(7):1253-8. PubMed ID: 15996060
    [Abstract] [Full Text] [Related]

  • 19. Infusion of epinephrine decreases serum levels of cortisol and 17-hydroxyprogesterone in patients with rheumatoid arthritis.
    Straub RH, Kittner JM, Heijnen C, Schedlowski M, Schmidt RE, Jacobs R.
    J Rheumatol; 2002 Aug; 29(8):1659-64. PubMed ID: 12180725
    [Abstract] [Full Text] [Related]

  • 20. Possible role of leptin in hypoandrogenicity in patients with systemic lupus erythematosus and rheumatoid arthritis.
    Härle P, Pongratz G, Weidler C, Büttner R, Schölmerich J, Straub RH.
    Ann Rheum Dis; 2004 Jul; 63(7):809-16. PubMed ID: 15194576
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.